Johnson & Johnson Quarterly Balance Sheet
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Johnson & Johnson financial position
As of Jun 28, 2026, Johnson & Johnson reported total assets of $201.06 billion, up 4.0% from a year earlier against total liabilities of $116.09 billion. Shareholders' equity stood at $84.97 billion, or 42.3% of assets. The company held $20.42 billion in cash and equivalents against $49.04 billion of debt, a net debt position of $28.61 billion.
The current ratio (current assets divided by current liabilities) was 1.09, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.58.
Summary generated from market data by MetaCap's automated system. Methodology
Johnson & Johnson balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-28 | Q1 20262026-03-29 | Q4 20252025-12-28 | Q3 20252025-09-28 | Q2 20252025-06-29 | Q1 20252025-03-30 | Q4 20242024-12-29 | Q3 20242024-09-29 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.42B | 21.69B | 19.71B | 18.23B | 18.58B | 38.47B | 24.11B | 19.98B | 24.88B | 25.47B | 21.86B | 19.73B |
| Short-Term Investments | 336.00M | 363.00M | 393.00M | 331.00M | 303.00M | 307.00M | 417.00M | 317.00M | 597.00M | 745.00M | 1.07B | 3.78B |
| Receivables | 19.05B | 17.72B | 17.18B | 17.61B | 17.85B | 16.02B | 14.84B | 16.17B | 15.79B | 14.95B | 14.87B | 14.80B |
| Inventory | 15.14B | 14.58B | 14.19B | 14.15B | 13.41B | 12.66B | 12.44B | 12.60B | 12.17B | 11.38B | 11.18B | 11.20B |
| Total Current Assets | 59.77B | 59.17B | 55.62B | 54.61B | 54.50B | 71.55B | 55.89B | 53.25B | 57.82B | 57.00B | 53.49B | 53.70B |
| Property, Plant & Equipment | 23.58B | 23.27B | 23.17B | 22.34B | 21.95B | 20.87B | 20.52B | 20.48B | 19.75B | 19.63B | 19.90B | 18.82B |
| Goodwill | 48.48B | 48.56B | 48.77B | 48.05B | 48.12B | 44.47B | 44.20B | 44.80B | 44.25B | 36.62B | 36.56B | 36.12B |
| Intangible Assets | 48.23B | 49.06B | 50.40B | 48.74B | 49.84B | 36.76B | 37.62B | 39.49B | 39.73B | 34.29B | 34.17B | 35.02B |
| Total Assets | 201.06B | 200.89B | 199.21B | 192.82B | 193.39B | 193.67B | 180.10B | 178.29B | 181.09B | 171.97B | 167.56B | 166.06B |
| Accounts Payable | 9.22B | 10.46B | 11.99B | 9.63B | 9.46B | 9.54B | 10.31B | 8.95B | 8.85B | 8.17B | 9.63B | 8.36B |
| Short-Term Debt | 11.69B | 17.46B | 8.50B | 6.39B | 11.53B | 13.90B | 6.00B | 4.46B | 9.86B | 8.55B | 3.50B | 3.87B |
| Total Current Liabilities | 54.90B | 57.72B | 54.13B | 50.87B | 54.18B | 56.90B | 50.32B | 51.76B | 53.93B | 48.73B | 46.28B | 44.37B |
| Long-Term Debt | 37.34B | 37.53B | 39.44B | 39.41B | 39.23B | 38.35B | 30.65B | 31.29B | 31.64B | 25.08B | 25.88B | 26.05B |
| Total Liabilities | 116.09B | 119.71B | 117.67B | 113.54B | 114.92B | 115.56B | 108.61B | 108.13B | 109.55B | 101.95B | 98.78B | 94.83B |
| Shareholders' Equity | 84.97B | 81.19B | 81.54B | 79.28B | 78.47B | 78.11B | 71.49B | 70.16B | 71.54B | 70.02B | 68.77B | 71.23B |
| Retained Earnings | 171.66B | 169.16B | 168.98B | 167.28B | 165.37B | 162.63B | 155.79B | 155.18B | 155.36B | 153.38B | 153.84B | 152.54B |
| Total Debt | 49.04B | 54.99B | 47.94B | 45.80B | 50.76B | 52.25B | 36.65B | 35.75B | 41.49B | 33.63B | 29.38B | 29.92B |
| Net Cash (Debt) | -28.28B | -32.94B | -27.84B | -27.23B | -31.88B | -13.47B | -12.13B | -15.45B | -16.02B | -7.41B | -6.45B | -6.41B |
This table shows 12 quarterly periods of Johnson & Johnson's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow JNJ's reporting calendar. What is a balance sheet?